Bristol Myers Squibb: A Value Contender in Pharma
Bristol Myers Squibb (BMY) shows compelling value with a low forward P/E and a 4.2% dividend yield, despite concerns over legacy drug...

Bristol Myers Squibb (BMY) shows compelling value with a low forward P/E and a 4.2% dividend yield, despite concerns over legacy drug...

Wheat futures traded mixed Monday, with Chicago SRW gaining while KC HRW and MPLS spring wheat slipped. Export data revealed strong marketing...

Robinhood has blocked certain prediction markets from its platform, citing concerns over insider trading and market abuse. The move follows examples of...

Singaporean stocks are nearing record highs, positioning the city-state as a robust haven for investors amidst escalating global volatility and geopolitical tensions.

President Trump is reportedly weighing military action against Iran, including limited strikes, after negotiations collapsed in Pakistan, The Wall Street Journal reported....

The global lithium market is undergoing a dramatic structural reversal, transitioning from a multi-year period of oversupply to a projected steep deficit...

Motley Fool experts Robert Brokamp and Stephanie Marini dissect the pros and cons of index funds and actively managed funds, offering insights...

Corn futures are showing fractional losses at midday, yet a significant private export sale and robust export commitments are helping the market...

Reform UK deputy leader Richard Tice's property company failed to pay £91,000 in tax on dividends, a lapse his party terms a...

Australia's Jindalee Lithium is spinning out its US asset portfolio into US Elemental, set to list on Nasdaq through a US$571 million...

May Nymex natural gas futures plunged to a 7.5-month low Friday, driven by forecasts for mild US spring weather reducing heating demand....

Leading AI assistants like ChatGPT, Grok, and Gemini consistently highlight Bitcoin, Ethereum, and Solana as top cryptocurrency recommendations for investors. Their reasoning...